Who invested in Arsanis?
Arsanis's investors include OrbiMed, Polaris Partners, SV Life Sciences, NeoMed and Alexandria Real Estate Equities, and 4 more on record.

Austria · Series D startup
Funding summaryUpdated 26 Oct 2026
$76Mraised across 4 rounds since 2010, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $46M sold, first sale Apr 2017
Reported by biospace.comSEC filing: $13M sold, first sale Jul 2013
Reported by news-medical.netSEC filing: $9.6M sold, first sale Jan 2011
No investor was named in the report.
From a historical funding recordSEC filing: $400K sold, first sale Sept 2010
From the SEC filings it signed: 5 on the team.
On the board, as filediAmy U. SchulmanCarl U. GordonClaudio U. NessiDavid U. McGirrMichael U. RossTerrance U. McGuireTillman U. GerngrossWilliam U. Clark
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Arsanis's investors include OrbiMed, Polaris Partners, SV Life Sciences, NeoMed and Alexandria Real Estate Equities, and 4 more on record.
Arsanis has raised $76M across 4 rounds since 2010.
Arsanis's most recent round was a Series D of $46M in Apr 2017.
Its most recent round, $46M in Apr 2017, is also its largest on record.
Arsanis's first round on record, in Feb 2011, was backed by Polaris Partners, OrbiMed and SV Life Sciences.
Arsanis's latest named round is a Series D, in Apr 2017.
Arsanis is based in Austria.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.